164 related articles for article (PubMed ID: 25120221)
1. Imaging spectrum of peritoneal carcinomatosis on FDG PET/CT.
Puranik AD; Purandare NC; Agrawal A; Shah S; Rangarajan V
Jpn J Radiol; 2014 Oct; 32(10):571-8. PubMed ID: 25120221
[TBL] [Abstract][Full Text] [Related]
2. Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis.
Cabral FC; Krajewski KM; Kim KW; Ramaiya NH; Jagannathan JP
Cancer Imaging; 2013 Apr; 13(2):162-70. PubMed ID: 23598428
[TBL] [Abstract][Full Text] [Related]
3. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal tuberculosis with elevated serum CA125 mimicking peritoneal carcinomatosis on F-18 FDG-PET/CT.
Chen CJ; Yao WJ; Chou CY; Chiu NT; Lee BF; Wu PS
Ann Nucl Med; 2008 Jul; 22(6):525-7. PubMed ID: 18670860
[TBL] [Abstract][Full Text] [Related]
5. Imaging spectrum and pitfalls of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis.
Ito K; Morooka M; Minamimoto R; Miyata Y; Okasaki M; Kubota K
Jpn J Radiol; 2013 Aug; 31(8):511-20. PubMed ID: 23719763
[TBL] [Abstract][Full Text] [Related]
6. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
[TBL] [Abstract][Full Text] [Related]
7. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
[TBL] [Abstract][Full Text] [Related]
8. Comparison of PET with PET/CT in detecting peritoneal carcinomatosis: a meta-analysis.
Li J; Yan R; Lei J; Jiang C
Abdom Imaging; 2015 Oct; 40(7):2660-6. PubMed ID: 25893503
[TBL] [Abstract][Full Text] [Related]
9. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities.
Kawata S; Imaizumi M; Kako Y; Oku N
Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705
[TBL] [Abstract][Full Text] [Related]
10. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
Zhou WL; Wu HB; Wang LJ; Tian Y; Dong Y; Wang QS
Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
[TBL] [Abstract][Full Text] [Related]
11. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
Sun Y; Lu P; Yu L
Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of (18)F-FDG PET/CT appearances in peritoneal disease.
Anthony MP; Khong PL; Zhang J
AJR Am J Roentgenol; 2009 Dec; 193(6):W523-9. PubMed ID: 19933627
[TBL] [Abstract][Full Text] [Related]
13. Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: a feasibility study.
Noij DP; Boerhout EJ; Pieters-van den Bos IC; Comans EF; Oprea-Lager D; Reinhard R; Hoekstra OS; de Bree R; de Graaf P; Castelijns JA
Eur J Radiol; 2014 Jul; 83(7):1144-1151. PubMed ID: 24768188
[TBL] [Abstract][Full Text] [Related]
14. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
15. Comparison of FDG-PET/CT and MR with diffusion-weighted imaging for assessing peritoneal carcinomatosis from gastrointestinal malignancy.
Soussan M; Des Guetz G; Barrau V; Aflalo-Hazan V; Pop G; Mehanna Z; Rust E; Aparicio T; Douard R; Benamouzig R; Wind P; Eder V
Eur Radiol; 2012 Jul; 22(7):1479-87. PubMed ID: 22358428
[TBL] [Abstract][Full Text] [Related]
16. PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum.
Wang SB; Ji YH; Wu HB; Wang QS; Zhou WL; Lv L; Shou T; Hu J
Medicine (Baltimore); 2017 Jan; 96(2):e5867. PubMed ID: 28079823
[TBL] [Abstract][Full Text] [Related]
17. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
18. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Stabile Ianora AA; Giganti M; Niccoli Asabella A
Recenti Prog Med; 2012 Nov; 103(11):510-4. PubMed ID: 23096741
[TBL] [Abstract][Full Text] [Related]
19. Preoperative assessment of peritoneal carcinomatosis in patients undergoing hyperthermic intraperitoneal chemotherapy following cytoreductive surgery.
Pasqual EM; Bertozzi S; Bacchetti S; Londero AP; Basso SM; Santeufemia DA; Lo Re G; Lumachi F
Anticancer Res; 2014 May; 34(5):2363-8. PubMed ID: 24778044
[TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
